Literature DB >> 20217493

Approaches for imaging islets: recent advances and future prospects.

Ulf Ahlgren1, Martin Gotthardt.   

Abstract

The establishment of improved technologies for imaging of the pancreas is a key element in addressing several aspects of diabetes pathogenesis. In this respect, the development of a protocol that allows for non-invasive scoring of human islets, or islet beta-cells, is of particular importance. The development of such a technology would have profound impact on both clinical and experimental medicine, ranging from early diagnosis of diabetes to the evaluation of therapeutic regimes. Another important task is the development of modalities for high-resolution imaging of experimental animal models for diabetes. Rodent models for diabetes research have for decades been instrumental to the diabetes research community. The ability to image, and to accurately quantify, key players of diabetogenic processes with molecular specificity will be of great importance for elucidating mechanistic aspects of the disease. This chapter aims to overview current progress within these research areas.

Entities:  

Mesh:

Year:  2010        PMID: 20217493     DOI: 10.1007/978-90-481-3271-3_3

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  15 in total

Review 1.  Mathematical models of pancreatic islet size distributions.

Authors:  Junghyo Jo; Manami Hara; Ulf Ahlgren; Robert Sorenson; Vipul Periwal
Journal:  Islets       Date:  2012-01-01       Impact factor: 2.694

Review 2.  Transdisciplinary approach to restore pancreatic islet function.

Authors:  Carmen Fotino; R Damaris Molano; Camillo Ricordi; Antonello Pileggi
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

3.  Accurate measurement of pancreatic islet beta-cell mass using a second-generation fluorescent exendin-4 analog.

Authors:  Thomas Reiner; Greg Thurber; Jason Gaglia; Claudio Vinegoni; Chong Wee Liew; Rabi Upadhyay; Rainer H Kohler; Li Li; Rohit N Kulkarni; Christophe Benoist; Diane Mathis; Ralph Weissleder
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-18       Impact factor: 11.205

Review 4.  The role of pancreatic imaging in monogenic diabetes mellitus.

Authors:  Ingfrid S Haldorsen; Helge Ræder; Mette Vesterhus; Anders Molven; Pål R Njølstad
Journal:  Nat Rev Endocrinol       Date:  2011-11-29       Impact factor: 43.330

5.  Beta cell specific probing with fluorescent exendin-4 is progressively reduced in type 2 diabetic mouse models.

Authors:  Janne Lehtonen; Lauge Schäffer; Morten Grønbech Rasch; Jacob Hecksher-Sørensen; Jonas Ahnfelt-Rønne
Journal:  Islets       Date:  2015       Impact factor: 2.694

6.  Magnetic resonance imaging of the pancreas in streptozotocin-induced diabetic rats: Gadofluorine P and Gd-DOTA.

Authors:  Hye Rim Cho; Youkyung Lee; Philip Doble; David Bishop; Dominic Hare; Young-Jae Kim; Kwang Gi Kim; Hye Seung Jung; Kyong Soo Park; Seung Hong Choi; Woo Kyung Moon
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

7.  The human L-type calcium channel Cav1.3 regulates insulin release and polymorphisms in CACNA1D associate with type 2 diabetes.

Authors:  T M Reinbothe; S Alkayyali; E Ahlqvist; T Tuomi; B Isomaa; V Lyssenko; E Renström
Journal:  Diabetologia       Date:  2012-11-15       Impact factor: 10.122

Review 8.  The Eye as a Transplantation Site to Monitor Pancreatic Islet Cell Plasticity.

Authors:  Erwin Ilegems; Per-Olof Berggren
Journal:  Front Endocrinol (Lausanne)       Date:  2021-04-23       Impact factor: 5.555

9.  Near infrared optical projection tomography for assessments of β-cell mass distribution in diabetes research.

Authors:  Anna U Eriksson; Christoffer Svensson; Andreas Hörnblad; Abbas Cheddad; Elena Kostromina; Maria Eriksson; Nils Norlin; Antonello Pileggi; James Sharpe; Fredrik Georgsson; Tomas Alanentalo; Ulf Ahlgren
Journal:  J Vis Exp       Date:  2013-01-12       Impact factor: 1.355

10.  Multimodal imaging of pancreatic beta cells in vivo by targeting transmembrane protein 27 (TMEM27).

Authors:  D Vats; H Wang; D Esterhazy; K Dikaiou; C Danzer; M Honer; F Stuker; H Matile; C Migliorini; E Fischer; J Ripoll; R Keist; W Krek; R Schibli; M Stoffel; M Rudin
Journal:  Diabetologia       Date:  2012-07-13       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.